Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vytorin Effects on Plaque in ACS
NCT01857843Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Nov 2009
- Primary completion
- Nov 2013
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised trial of Vytorin in acute coronary syndrome (ACS) (4 arms), sponsored by Yonsei University. Primary endpoint: Quantitative change in fibrofatty component of plaque measured by VH-IVUS at 3 months. Started Nov 2009; status: completed.
02
Drugs
Vytorin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01857843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857843.